baber/WOPTO huggingface dataset:
Patent CS-249146-B2 (CS)
Title: Method of new imidazodiazepine's derivatives production
Inventor: HUNKELER WALTER
IPC: C07D333/00
Filed: 1985-01-16
Abstract: There is presented compounds of the formula    <IMAGE>  I  wherein A together with the two carbon atoms denoted by  alpha  and  beta signifies one of the groups    <IMAGE> (1)   <IMAGE> (2)   <IMAGE> (3)  and   <IMAGE> (4)  and the dotted line signifies the double bond present in cases (1), (2) and (4) and wherein R1 signifies a 5- or 6-membered aromatic heterocyclic group or the group -C(R6)=NOR7(B), R2 signifies hydrogen and R3 signifies hydrogen or lower alkyl or R2 and R3 together signify dimethylene, trimethylene or propenylene, R4 and R5 each signify hydrogen, halogen, trifluoromethyl, cyano, nitro, amino or lower alkyl, R6 signifies hydrogen or lower alkyl and R7 signifies lower alkyl, the compound of formula I having the (S) or (R,S) configuration with reference to the carbon atom denoted by gamma  when R2 and R3  together signify dimethylene, trimethylene or propenylene, and pharmaceutically acceptable acid addition salts thereof have a pronounced affinity to the central benzodiazepine receptors and have anxiolytic, anticonvulsant, muscle relaxant and sedative-hypnotic properties.
Patent CS-259860-B2 (CS)
Title: Composition for injection shaping
Inventor: WITTWER FRITZ
IPC: C08L89/00
Filed: 1983-03-28
Abstract: A moldable hydrophilic polymer composition, preferably gelatin, for use in the combination of a capsule injection molding device with a microprocessor. The composition has a molecular mass range of 10,000 to 2,000,000 Dalton or a molecular mass range of 10,000 to 2,000,000 and 10,000,000 to 20,000,000 Dalton. The composition has a water content range from 5 to 25% percent by weight.
Patent CS-231157-B2 (CS)
Title: Processing method of klavulan acid and corresponding salts and esters
Inventor: COLE MARTIN
IPC: C12P1/04
Filed: 1975-04-18
Abstract: 1508977 Antibiotic compositions containing clavulanic add BEECHAM GROUP Ltd 11 April 1975 17410/74 27715/74 43651/74 and 53525/74 Heading A5B [Also in Division C2] Pharmaceutical compositions having antibacterial activity comprise, as active ingredient clavulanic acid of the formula or a pharceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier and optionally other therapeutically active agents such as #-lactam antibiotics, e.g. benzylpenicillin, phenoxymethylpenicillin, carbenicillin, methicillin, propioillin, ampicillin, amoxycillin, epicillin, ticarcillin, cyclacillin, 6- aminopenicillanic acid, 7 - aminocephalosporanic acid, 7 - aminodesacetoxycephalosporanic acid, cephaloridine, cephalothin, cephazolin, cephalexin, cefoxitin, cephacetrile, cephamandole, cephapirin, cephradine, cephaloglycine, hetaoillin, metampicillin, the acetoxymethyl, pivaloyloxymethyl or phthalidyl esters of benzylpenicillin, ampicillin, amoxyoillin or cephaloglycine or the phenyl, tolyl or indanyl α-esters of carbenicillin or ticarcillin. They may be administered orally, topically or parenterally e.g. as tablets, capsules, creams, syrups, suspensions, solutions, reconstitutable powders and sterile forms suitable for injection or infusion.
Patent CS-199506-B2 (CS)
Title: Insecticide,acaricide and nematocide and process for preparing effective compounds
Inventor: ARLD DIETER
IPC: C07F9/6533
Filed: 1977-06-29
Abstract: Phosphorus acid ester amides of formula (I) are new (where R and R1 are H, alkyl opt. substd. by halo; or CN; or R and R1 together with the attached N atom form a heterocyclic ring opt. interrupted by other heteroatoms; R2 is the group -NRR1, alkoxy, haloalkoxy or alkyl; hal is Cl or Br; X is O or S). (I) are insecticides, acaricides and nematocides with low toxicity to man and animals. A typical cpd., O-(1-fluoro-2-chloroethyl) phosphoro-dimorpholide, was prepd. in 70% yield by reaction of morpholine with O-(1-fluoro-2-chloroethyl) phosporo-dichloride in benzene.
Patent CS-239917-B2 (CS)
Title: Cigarette filter
Inventor: SANFORD ROBERT A
IPC: A24D3/04
Filed: 1981-12-07
Abstract: A filter for a cigarette includes a porous filter rod circumscribed by a smoke impervious wrapper wherein the filter rod with the smoke impervious wrapper therearound is provided with grooves embedded therein and extending from one end thereof a preselected distance longitudinally therealong. Tipping material circumscribes the smoke impervious wrapper and is provided with flow-through openings therein in flow communication with the grooves. Support means are provided for the tipping material at the mouth end of the filter to maintain the tipping material in circumferential equalization.
Patent JP-3336328-B2 (JP)
IPC: H01L23/50
Filed: 1996-01-17
Granted: 2002-10-21
Abstract: PROBLEM TO BE SOLVED: To prevent a wire for switching memory mats being exposed on the main surface of a semiconductor chip from being cracked. SOLUTION: A device consists of a semiconductor chip 3 with a wiring and a bonding pad exposed on a main surface, a lead 2 which is partially insulated and fixed to the main surface of the semiconductor chip via an insulation film 7, a connecting means for electrically connecting the lead and the bonding pad, and a resin sealing body 1 for covering one portion of the semiconductor chip 3 and the lead as well as the connecting means, the tip of the lead protrudes outward from the resin sealing body 1, thus constituting an external terminal. In this case, the lead extended directly above the wiring is partially bent and opposes the wiring with a wider interval than the size of a filler for forming the resin sealing body.
Patent AU-539262-B2 (AU)
Title: Chromogenic ester and 3-quinuclidinol color detectors of leukocyte and esterase activity
Inventor: SKJOLD A CHRISTOPHER
IPC: C12Q1/34
Filed: 1983-01-05
Granted: 1984-09-20
Abstract: A composition, test device and method for determining the presence of leukocytes, esterase and/or esterase activity in a test sample is disclosed. The composition comprises an ester which, when cleaved by esterolytic activity, produces a detectable response such as color formation. In addition the composition comprises the compound 3-quinuclidinol. The device is prepared by incorporating a carrier matrix, such as paper, with the composition. The method comprises contacting a test sample with the device and observing a detectable response.
Patent AU-597141-B2 (AU)
Title: 3(2h)pyridazinone, process for its preparation and antagonistic agent against srs-a containing it
Inventor: TANIKAWA KEIZO
IPC: C07D237/22
Filed: 1988-01-19
Granted: 1990-05-24
Abstract: A 3(2H)pyridazinone of the formula: <CHEM> wherein R1 is hydrogen, 2-propenyl or straight chained or branched C1-C4 alkyl; R2 is hydrogen or C1-C3 alkyl; X is chlorine or bromine; Y is hydrogen, nitro, -NHR3 wherein R3 is hydrogen or straight chained or branched C1-C4 alkyl, -AR4 wherein A is oxygen or sulfur and R4 is hydrogen, straight chained or branched C1-C6 alkyl, C3-C6 alkenyl having one double bond, C3-C6 alkynyl having one triple bond, phenyl or <CHEM> wherein R5 is hydrogen or C1-C4 alkyl, or halogen; Z1 is hydrogen, C1-C4 alkyl, -OR6 wherein R6 is hydrogen, straight chained or branched C1-C8 alkyl or <CHEM> wherein n is an integer of from 1 to 4, -N(R7)2 wherein R7 is C1-C4 alkyl, or halogen; Z2 is C1-C4 alkyl, -OR6 wherein R6 is as defined above, -N(R7)2 wherein R7 is as defined above, or halogen, provided that when R1 is straight chained or branched C2-C4 alkyl, Y is not hydrogen and when R1 is hydrogen, methyl or 2-propenyl, Y and R2 are not simultaneously hydrogen, or a pharmaceutically acceptable salt thereof.
Patent AU-777228-B2 (AU)
Title: Method and apparatus for opthalmic refractive correction
Inventor: HOHLA KRISTIAN
IPC: A61F9/007
Filed: 2000-10-20
Granted: 2004-10-07
Abstract: An aperture card is provided for insertion into a laser refractive ablation system for use in laser ablating the cornea. The aperture card is designed for single surgical use for surgical precautionary considerations and to achieve the highest quality ablations, in addition to reproducibility. The aperture card is loaded into the laser refractive ablation system in a path between the laser system and the eye. The aperture card is precisely located by positioning means and ablative lasing action is inhibited if the card is not positioned within tolerance. Alternatively, the laser system can determine the position of the aperture card and adjust a computed ablation profile or otherwise adjust the optical system to adapt for any misalignment of the apertures in the aperture card. The card contains a "soft spot" aperture capable of shaping a spatial intensity distribution with a unique profile. The profile has a substantially flat top while the sides of the profile slope until an ablation intensity threshold is reached, at which point the sides become substantially vertical. The card can contain more than one soft spot aperture along with a "hard spot" aperture that creates a square-shaped profile used for testing fluence. Each soft spot aperture is formed by a central aperture and a plurality of holes of different sizes surrounding the central aperture and arranged such that the overall diffractive effect produces a soft spot spatial intensity profile compared to the hard, square-sided profile.
Patent AU-658863-B2 (AU)
Title: Determination of tricyclic antidepressant drugs in the presence of interfering substances
Inventor: ADAMCZYK MACIEJ
IPC: G01N30/06
Filed: 1991-12-13
Granted: 1995-05-04
Abstract: Method and reagents for determining a compound of interest present in a test sample also containing one or more interfering compounds having substantially similar chemical structures, and otherwise analytically indistinguishable from each other, employing a pretreatment reagent capable of selectively modifying the chemical structure of one of the compounds without significantly modifying or altering the chemical structure of the other one of the compounds. The selective modification results in the modified compound having a chemical structure which is substantially dissimilar to the chemical structure of the other one of said compounds wherein the compounds are substantially distinguishable from each other to permit the analytical determination of one or the other of such compounds by immunoassay, high pressure liquid chromatography, and thin layer chromatography techniques, especially for the fluorescent polarization immunoassay determination of tricyclic antidepressant drugs in the presence of phenothiazines.
Patent AU-736853-B2 (AU)
Title: New and improved method and apparatus for fastening gutters to structures
Inventor: WILLERT WAYNE A
IPC: E04D13/072
Filed: 1998-10-27
Granted: 2001-08-02
Abstract: A gutter fastener (10) having a first shank portion (14) with a head (12a) integrally formed on one end and a second shank portion (16) integrally formed with the opposite end. The first shank portion has a length (L1) substantially equal to the water collecting opening in a gutter (20), while the second shank portion has a length (L2) substantially equal to one half the length of the first shank portion. The second shank portion includes screw-like threads (50) for engaging the facial panel (24) behind a gutter and enabling a more secure connection between the two.
Patent AU-731922-B2 (AU)
Title: Packaging of smoking articles
Inventor: PARKER MICHAEL PATRICK
IPC: B60B37/10
Filed: 1998-12-02
Granted: 2001-04-05
Abstract: A rigid of smoking articles is made to have improved shelf life and to be resealable. A barrier material is sealed around the rigid pack. The rigid pack has a potential or actual access aperture extending from a top face into a major face. The barrier material has a line of severance or weakening defining a flap, which is in register with the potential or actual access aperture. Over the flap is a layer which overlaps it on each severable side with a portion having permanently-tacky adhesive. A non-adhered pull tab is preferably provided on the layer. To open the pack the user lifts the flap and if necessary the access aperture. After removal of a smoking article the gap in the barrier layer is reclosed and released by the repositioning of the adhesive layer, carrying with it the flap of barrier material. A machine for assembling the pack is also disclosed.
Patent AU-543875-B2 (AU)
Title: Surgical stapler
Inventor: BLAKE JOSEPH WALTER
IPC: A61B17/10
Filed: 1983-05-03
Granted: 1985-05-09
Abstract: A skin stapler having a plurality of staples is disclosed comprising a frame structure, with a nose section for directing the staple at a wound site, and including a housing therein having an anvil, a staple ejector, a driver for deforming the staple about the anvil, and a staple follower for continually urging the staples against a release member. Means are also provided for actuating the driver in a substantially translatable direction; the actuating means comprises a toggle mechanism. In addition, the stapler is provided with means for restoring the driver to its unactivated position, and means are provided for preventing the double loading of the staples in said surgical stapler. The skin stapler is lightweight and of the disposable type as it is generally small and relatively compact.
Patent AU-596299-B2 (AU)
Title: Carton with improved handle
Inventor: SCHUSTER RICHARD LEE
IPC: B65D/
Filed: 1988-03-21
Granted: 1990-04-26
Abstract: A carton contains a flap on the outer top panel and a flap on the inner top panel, the free edge of the outer top panel flap overlying the inner top panel flap. When a user presses down on the outer top panel flap, it pivots out of the way to allow the user's fingers to fold the inner top panel flap under the top panel structure to provide a handle for lifting the carton. When the fingers are withdrawn, the outer top panel flap is biased upwardly by its arcuate foldable connection to close the handle opening. If the inner top panel flap is contacted by the outer top panel flap as it pivots upwardly, the outer top panel flap pushes the inner top panel flap up to a substantially closed position. Score lines extending from the ends of the foldable connections of the inner and outer top panel flaps to the corners of the carton distribute the lifting stresses to the side panels of the carton.
Patent AU-556672-B2 (AU)
Title: Stabilisation of vinyl chloride polymers
Inventor: CARETTE LOUIS
IPC: C08F2/44
Filed: 1983-06-30
Granted: 1986-11-13
Abstract: 1. Process for the prestabilisation of polymers based on vinyl chloride, characterised in that effective amounts of at least one organic or inorganic zinc compound and of at least one beta-diketone or beta-ketoaldehyde are added to the monomer or comonomers, before or during the polymerisation leading to the said polymers.
Patent AU-599238-B2 (AU)
Title: Fillers
Inventor: ROTHON ROGER NORMAN
IPC: C08K9/10
Filed: 1988-06-10
Granted: 1990-07-12
Abstract: A cohesive polymer matrix comprising a matrix a matrix polymer and a coated particulate filler dispersed therein, characterised in that the matrix polymer is an acrylic polymer, and the filler is coated at least in part with a composition comprising an organic coating polymer of number average molecular weight of up to 300,000, which contains an acidic group (or precursor thereof) and an unsaturated group optionally linked to the matrix acrylic polymer, and a process for its production, and precursors thereof for use in the process.
Patent AU-732560-B2 (AU)
Title: Chewing gum and gum bases with reduced adhesion to environmental surfaces
Inventor: BUNCZEK MICHAEL T
IPC: A23G4/06
Filed: 1998-12-17
Granted: 2001-04-26
Abstract: A gum base including an alkyl substituted polydimethylsiloxane. Chewing gums made from the gum base as well as methods for manufacturing chewing gum and gum bases are disclosed.
Patent AU-557562-B2 (AU)
Title: Separating sausage links
Inventor: ZIOLKO FRANCIS JOSEPH
IPC: A22C11/12
Filed: 1983-11-09
Granted: 1986-12-24
Abstract: An apparatus for separating sausage links is disclosed. The apparatus has a series of pairs (34) of cutting arms (70, 72) mounted on a circular plate (60). The arms are moved into contact with the sausage links (58). As a pair of cutting arms contact the sausage links from opposite sides, they force the links away from the point of contact. There is a cutting element (64) at the end of each arm which cuts the casing between the links when the arms overlap.
Patent AU-740468-B2 (AU)
Title: Matrix protein compositions for wound healing
Inventor: GESTRELIUS STINA
IPC: A61P31/04
Filed: 1999-02-26
Granted: 2001-11-08
Abstract: Active enamel substances may be used for the preparation of a pharmaceutical or cosmetic composition for healing of a wound, improving healing of a wound, soft tissue regeneration or repair, or for preventing or treating infection or inflammation.
Patent AU-547206-B2 (AU)
Title: Timer mode selection
Inventor: ARICHI ISAO
IPC: H01H43/10
Filed: 1984-03-29
Granted: 1985-10-10
Abstract: A mode selection arrangement for use in a timer includes a gear box and a printed circuit board provided at the back of the gear box. Predetermined contact patterns are formed on a face of the printed circuit board facing the gear box. Rotatably provided in the gear box are display gears and switch gears. Each display gear has a plurality of indicia depicted on its face, and the corresponding switch gear rotates operatively or integrally with the display gear. A sliding contact member is fixedly attached to each switch gear, so that the sliding contact member sligingly contacts the corresponding contact pattern. A front plate having windows formed therein is provided to close the gear box so that the indicia are displayed through the windows.
Patent AU-659501-B2 (AU)
Title: Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-D-neuraminic acid
Inventor: ITZSTEIN LAURENCE MARK VON
IPC: C07D309/28
Filed: 1992-10-21
Granted: 1995-05-18
Abstract: N-Acetylneuraminic and derivatives of formula (I) <CHEM> (wherein R, R<1>, R<2>, R<3> and R4 are defined in the specification) pharmaceutical formulations thereof, their use in medicine, in particular as antiviral agents and methods for their preparation are described.
Patent AU-663340-B2 (AU)
Title: Method of controlling wastewater purification plants using multiple control functions
Inventor: NIELSEN MARINUS KRISTIAN
IPC: C02F3/02
Filed: 1992-10-01
Granted: 1995-10-05
Abstract: PCT No. PCT/DK92/00290 Sec. 371 Date Mar. 22, 1994 Sec. 102(e) Date Mar. 22, 1994 PCT Filed Oct. 1, 1992 PCT Pub. No. WO93/07088 PCT Pub. Date Apr. 15, 1993A method of automatically controlling a wastewater purification plant comprises the steps of measuring two or more of a number of parameters, determining a control parameter on the basis of the measurement results obtained and at least two selected control functions, selecting a control action on the basis of the determined control parameter and subsequently implementing the selected control action.
Patent AU-608682-B2 (AU)
Title: Intermediates useful in the preparation of amino thiol dipeptides
Inventor: GORDON ERIC MICHAEL
IPC: C07K5/06
Filed: 1989-01-16
Granted: 1991-04-11
Abstract: Amino thiol substituted dipeptides of the formulaare disclosed. These compounds are useful as hypotensive agents due to their angiotensin coverting enzyme inhibition activity and are also useful as analgesics due to enkephalinase inhibition activity when X is
Patent AU-738176-B2 (AU)
Title: Dissolvable oxides for biological applications
Inventor: AHOLA MANJA
IPC: A61K9/06
Filed: 1997-05-29
Granted: 2001-09-13
Abstract: A controllable dissolvable silica-xerogel prepared via sol-gel process is new. Also claimed are particles of the silica-xerogel, and a delivery device, comprising the silica-xerogel and a biologically active agent in the gel.
Patent AU-748992-B2 (AU)
Title: Recombinant onconase, and chemical conjugates and fusion proteins of recombinant onconase
Inventor: GOLDENBERG DAVID M
IPC: A61K38/00
Filed: 1999-03-11
Granted: 2002-06-13
Abstract: Recombinantly-produced Onconase molecules and fusion proteins containing the same are disclosed. The recombinantly-produced Onconase molecule has the sequence of native Onconase, retains the proper folding of native Onconase and has cytotoxic activity similar to that of Onconase purified from oocytes of Rana pipiens. cDNA coding for Onconase is extended by one triplet which codes for N-formyl-methionine. When expressed recombinantly, the mutant Onconase has N-formyl-methionine as the N-terminal amino acid, and glutaminyl as the penultimate N-terminal residue. Following expression, the N-formyl methionine residue is cleaved and the penultimate glutaminyl residues are cyclized to produce Onconase with an N-terminal pyroglutamate residue, and hence the same structure and function as native Onconase.
Patent AU-612248-B2 (AU)
Title: Process for the control of biological clarification stages
Inventor: NADER WERNER DR
IPC: C02F3/00
Filed: 1989-03-22
Granted: 1991-07-04
Abstract: To control a biological clarification stage of the aerobic activated sludge type, one or more of the micro-organisms most frequently present in the activated sludge are monitored continuously with respect to the amount present by, in a representative sample taken from the activated sludge and/or the feed, to the activated sludge basin binding these micro-organisms to fluorescence-labelled antibodies specific to the selected micro-organisms or by allowing these micro-organisms to convert fluorogenous substrate through a specific metabolic activity, determining the quantity of micro-organisms fluorescence-labelled in this way by through-flow cytometry and, at the same time, determining the total quantity of micro-organisms present by scattered light measurement and/or staining of the DSN and, dependent on the measurement values thus obtained, controlling the quantity of one or more of the micro-organisms determined and/or the growth conditions for these micro-organisms. 
<IMAGE>